| Year |
Citation |
Score |
| 2018 |
Seiler M, Yoshimi A, Darman R, Chan B, Keaney G, Thomas M, Agrawal AA, Caleb B, Csibi A, Sean E, Fekkes P, Karr C, Klimek V, Lai G, Lee L, ... ... Yao H, et al. H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers. Nature Medicine. PMID 29457796 DOI: 10.1038/Nm.4493 |
0.416 |
|
| 2018 |
Korpal M, Puyang X, Furman C, Zheng G, Banka D, Wu J, Zhang Z, Thomas M, Mackenzie C, Yao H, Rimkunas V, Kumar P, Caleb B, Karr C, Subramanian V, et al. Abstract P1-10-08: Development of a first-in-class oral selective ERα covalent antagonist (SERCA) for the treatment of ERαWT and ERαMUT breast cancer Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-P1-10-08 |
0.305 |
|
| 2017 |
Smith PG, Puyang X, Furman C, Zheng GZ, Banka D, Thomas M, Subramanian V, Irwin S, Larsen N, Caleb B, Karr C, Wu J, O’Shea M, Yang J, Davis A, ... ... Yao H, et al. Abstract DDT01-04: Discovery and development of H3B-6545: A novel, oral, selective estrogen receptor covalent antagonist (SERCA) for the treatment of breast cancer Cancer Research. 77. DOI: 10.1158/1538-7445.Am2017-Ddt01-04 |
0.315 |
|
| 2017 |
Buonamici S, Yoshimi A, Thomas M, Seiler M, Chan B, Caleb B, Csibi F, Darman R, Fekkes P, Karr C, Keaney G, Kim A, Klimek V, Kumar P, Kunii K, ... ... Yao H, et al. Abstract 1185: H3B-8800, a novel orally available SF3b modulator, shows preclinical efficacy across spliceosome mutant cancers Cancer Research. 77: 1185-1185. DOI: 10.1158/1538-7445.Am2017-1185 |
0.436 |
|
| 2016 |
Gao M, Yao H, Dong Q, Zhang H, Yang Z, Yang Y, Zhu J, Xu M, Xu R. Tumourigenicity and Immunogenicity of Induced Neural Stem Cell Grafts Versus Induced Pluripotent Stem Cell Grafts in Syngeneic Mouse Brain. Scientific Reports. 6: 29955. PMID 27417157 DOI: 10.1038/srep29955 |
0.314 |
|
| 2016 |
Ping N, Sun A, Song Y, Wang Q, Yin J, Cheng W, Xu Y, Wen L, Yao H, Ma L, Qiu H, Ruan C, Wu D, Chen S. Exome sequencing identifies highly recurrent somatic GATA2 and CEBPA mutations in acute erythroid leukemia. Leukemia. PMID 27389056 DOI: 10.1038/leu.2016.162 |
0.3 |
|
| 2016 |
Kang HS, Chen LY, Lichti-Kaiser K, Liao G, Gerrish K, Bortner CD, Yao HH, Eddy EM, Jetten AM. Transcription Factor GLIS3: a New and Critical Regulator of Postnatal Stages of Mouse Spermatogenesis. Stem Cells (Dayton, Ohio). PMID 27350140 DOI: 10.1002/stem.2449 |
0.41 |
|
| 2015 |
Yao H, Goldman DC, Fan G, Mandel G, Fleming WH. The co-repressor Rcor1 is essential for normal myeloerythroid lineage differentiation. Stem Cells (Dayton, Ohio). PMID 26119982 DOI: 10.1002/Stem.2086 |
0.597 |
|
| 2014 |
McGann JC, Oyer JA, Garg S, Yao H, Liu J, Feng X, Liao L, Yates JR, Mandel G. Polycomb- and REST-associated histone deacetylases are independent pathways toward a mature neuronal phenotype. Elife. 3: e04235. PMID 25250711 DOI: 10.7554/Elife.04235 |
0.582 |
|
| 2014 |
Yao H, Goldman DC, Nechiporuk T, Kawane S, McWeeney SK, Tyner JW, Fan G, Kerenyi MA, Orkin SH, Fleming WH, Mandel G. Corepressor Rcor1 is essential for murine erythropoiesis. Blood. 123: 3175-84. PMID 24652990 DOI: 10.1182/Blood-2013-11-538678 |
0.599 |
|
| 2014 |
Goldman DC, Yao H, Fan G, Mandel G, Fleming WH. Rcor1 Deficiency Disrupts Myeloerythroid Lineage Differentiation and Causes Severe Myelodysplasia Blood. 124: 3248-3248. DOI: 10.1182/Blood.V124.21.3248.3248 |
0.584 |
|
| 2013 |
Xu J, Bauer DE, Kerenyi MA, Vo TD, Hou S, Hsu YJ, Yao H, Trowbridge JJ, Mandel G, Orkin SH. Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A. Proceedings of the National Academy of Sciences of the United States of America. 110: 6518-23. PMID 23576758 DOI: 10.1073/Pnas.1303976110 |
0.56 |
|
| 2008 |
Toh SY, Gong J, Du G, Li JZ, Yang S, Ye J, Yao H, Zhang Y, Xue B, Li Q, Yang H, Wen Z, Li P. Up-regulation of mitochondrial activity and acquirement of brown adipose tissue-like property in the white adipose tissue of fsp27 deficient mice. Plos One. 3: e2890. PMID 18682832 DOI: 10.1371/Journal.Pone.0002890 |
0.369 |
|
| Show low-probability matches. |